RecruitingNot ApplicableNCT06811311

EEG Study on Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy in Generalized Anxiety Disorder

Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy on Generalized Anxiety Disorder: An EEG-Based Clinical Study


Sponsor

Uskudar University

Enrollment

60 participants

Start Date

Feb 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study examines the neurophysiological and psychological effects of Ericksonian hypnotherapy in individuals diagnosed with Generalized Anxiety Disorder (GAD). Using electroencephalography (EEG), the study aims to assess changes in brain activity and anxiety symptoms before and after treatment. A total of 60 participants will be recruited from both governmental and private psychiatric clinics in Istanbul. Participants will be randomly assigned to either the intervention group (receiving 12 Ericksonian hypnotherapy sessions over 12 weeks) or the control group (receiving no intervention). The primary outcome measures include changes in EEG patterns, specifically alpha, theta, and frontal asymmetry indices, and changes in anxiety severity, measured by the Beck Anxiety Inventory (BAI), Generalized Anxiety Disorder-7 (GAD-7), and State-Trait Anxiety Inventory (STAI). Secondary measures include emotional regulation (DERS) and quality of life (WHOQOL-BREF). This study aims to provide scientific evidence on the effectiveness of Ericksonian hypnotherapy as a complementary treatment for GAD and its impact on brain function and emotional well-being.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is using brainwave recordings (EEG) to measure how Ericksonian hypnotherapy — a gentle, conversational form of hypnosis — affects the brain and emotional state of people with generalized anxiety disorder (GAD), a condition involving excessive worry that is hard to control. **You may be eligible if...** - You have been diagnosed with generalized anxiety disorder (GAD) based on standard criteria - You are between 18 and 65 years old - You are fluent in Turkish - You are not currently receiving any other treatment for anxiety (no therapy or medication) - You have never had hypnotherapy before **You may NOT be eligible if...** - You have another serious psychiatric condition (such as schizophrenia, bipolar disorder, or severe depression) - You have a neurological condition (such as epilepsy, stroke, or brain injury) - You currently take medications that affect brain activity (such as benzodiazepines, antidepressants, or antipsychotics) - You have used substances problematically in the past 6 months - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEricksonian Hypnotherapy

Ericksonian hypnotherapy is a therapeutic approach that utilizes indirect suggestion, storytelling, and metaphorical language to induce a trance state and facilitate psychological change. This intervention aims to reduce anxiety symptoms, improve emotional regulation, and alter neurophysiological responses as measured by EEG. Participants will undergo 12 individual sessions, each lasting 90 minutes, over a period of 12 weeks.


Locations(1)

Üsküdar University, Neuro-Psychology Lab

Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06811311


Related Trials